Annual CFO
-$67.27 M
+$9.86 M+12.79%
31 December 2023
Summary:
AC Immune SA annual cash flow from operations is currently -$67.27 million, with the most recent change of +$9.86 million (+12.79%) on 31 December 2023. During the last 3 years, it has fallen by -$3.79 million (-5.97%). ACIU annual CFO is now -221.04% below its all-time high of $55.58 million, reached on 31 December 2019.ACIU Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$12.60 M
-$93.31 M-115.61%
01 September 2024
Summary:
AC Immune SA quarterly cash flow from operations is currently -$12.60 million, with the most recent change of -$93.31 million (-115.61%) on 01 September 2024. Over the past year, it has increased by +$3.07 million (+19.58%). ACIU quarterly CFO is now -115.61% below its all-time high of $80.71 million, reached on 30 June 2024.ACIU Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$52.07 M
+$3.07 M+6.26%
01 September 2024
Summary:
AC Immune SA TTM cash flow from operations is currently $52.07 million, with the most recent change of +$3.07 million (+6.26%) on 01 September 2024. Over the past year, it has increased by +$121.13 million (+175.41%). ACIU TTM CFO is now -8.28% below its all-time high of $56.77 million, reached on 30 September 2019.ACIU TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACIU Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.8% | +19.6% | +175.4% |
| 3 y3 years | -6.0% | +18.7% | +172.4% |
| 5 y5 years | -49.3% | -169.3% | -8.3% |
ACIU Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.0% | +12.8% | -115.6% | +49.7% | at high | +165.6% |
| 5 y | 5 years | -221.0% | +12.8% | -115.6% | +49.7% | -8.3% | +165.6% |
| alltime | all time | -221.0% | +12.8% | -115.6% | +49.7% | -8.3% | +165.6% |
AC Immune SA Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.60 M(-115.6%) | $52.07 M(+6.3%) |
| June 2024 | - | $80.71 M(+6788.2%) | $49.00 M(-202.2%) |
| Mar 2024 | - | $1.17 M(-106.8%) | -$47.96 M(-28.7%) |
| Dec 2023 | -$67.27 M(-12.8%) | -$17.21 M(+9.8%) | -$67.27 M(-2.6%) |
| Sept 2023 | - | -$15.67 M(-3.6%) | -$69.06 M(+2.5%) |
| June 2023 | - | -$16.26 M(-10.4%) | -$67.37 M(-4.1%) |
| Mar 2023 | - | -$18.14 M(-4.5%) | -$70.22 M(-9.0%) |
| Dec 2022 | -$77.14 M(+7.3%) | -$18.99 M(+35.8%) | -$77.14 M(-1.0%) |
| Sept 2022 | - | -$13.98 M(-26.8%) | -$77.89 M(-1.9%) |
| June 2022 | - | -$19.11 M(-23.7%) | -$79.41 M(+2.1%) |
| Mar 2022 | - | -$25.06 M(+26.9%) | -$77.76 M(+8.2%) |
| Dec 2021 | -$71.87 M(+13.2%) | -$19.74 M(+27.3%) | -$71.87 M(-0.1%) |
| Sept 2021 | - | -$15.50 M(-11.2%) | -$71.95 M(-3.6%) |
| June 2021 | - | -$17.46 M(-8.9%) | -$74.63 M(+2.7%) |
| Mar 2021 | - | -$19.17 M(-3.3%) | -$72.64 M(+14.4%) |
| Dec 2020 | -$63.48 M(-214.2%) | -$19.82 M(+9.0%) | -$63.48 M(+11.3%) |
| Sept 2020 | - | -$18.18 M(+17.5%) | -$57.06 M(+175.6%) |
| June 2020 | - | -$15.47 M(+54.5%) | -$20.71 M(+0.3%) |
| Mar 2020 | - | -$10.01 M(-25.3%) | -$20.65 M(-137.2%) |
| Dec 2019 | $55.58 M | -$13.40 M(-173.7%) | $55.58 M(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $18.17 M(-217.9%) | $56.77 M(+113.9%) |
| June 2019 | - | -$15.42 M(-123.3%) | $26.54 M(-24.7%) |
| Mar 2019 | - | $66.22 M(-642.4%) | $35.24 M(-178.2%) |
| Dec 2018 | -$45.06 M(+100.9%) | -$12.21 M(+1.2%) | -$45.06 M(+75.2%) |
| Sept 2018 | - | -$12.06 M(+79.5%) | -$25.72 M(+16.9%) |
| June 2018 | - | -$6.72 M(-52.3%) | -$21.99 M(-10.8%) |
| Mar 2018 | - | -$14.07 M(-297.4%) | -$24.67 M(+10.0%) |
| Dec 2017 | -$22.43 M(+291.3%) | $7.13 M(-185.6%) | -$22.43 M(-38.7%) |
| Sept 2017 | - | -$8.33 M(-11.3%) | -$36.59 M(+87.3%) |
| June 2017 | - | -$9.39 M(-20.6%) | -$19.54 M(+98.8%) |
| Mar 2017 | - | -$11.83 M(+68.2%) | -$9.83 M(+71.5%) |
| Dec 2016 | -$5.73 M(-112.5%) | -$7.04 M(-180.7%) | -$5.73 M(+31.6%) |
| Sept 2016 | - | $8.72 M(+2637.1%) | -$4.35 M(-120.4%) |
| June 2016 | - | $318.60 K(-104.1%) | $21.35 M(+28.2%) |
| Mar 2016 | - | -$7.74 M(+36.7%) | $16.65 M(-63.6%) |
| Dec 2015 | $45.81 M(-337.6%) | -$5.66 M(-116.4%) | $45.81 M(-11.0%) |
| Sept 2015 | - | $34.42 M(-886.6%) | $51.47 M(+201.9%) |
| June 2015 | - | -$4.38 M(-120.4%) | $17.05 M(-20.4%) |
| Mar 2015 | - | $21.42 M | $21.42 M |
| Dec 2014 | -$19.28 M | - | - |
FAQ
- What is AC Immune SA annual cash flow from operations?
- What is the all time high annual CFO for AC Immune SA?
- What is AC Immune SA annual CFO year-on-year change?
- What is AC Immune SA quarterly cash flow from operations?
- What is the all time high quarterly CFO for AC Immune SA?
- What is AC Immune SA quarterly CFO year-on-year change?
- What is AC Immune SA TTM cash flow from operations?
- What is the all time high TTM CFO for AC Immune SA?
- What is AC Immune SA TTM CFO year-on-year change?
What is AC Immune SA annual cash flow from operations?
The current annual CFO of ACIU is -$67.27 M
What is the all time high annual CFO for AC Immune SA?
AC Immune SA all-time high annual cash flow from operations is $55.58 M
What is AC Immune SA annual CFO year-on-year change?
Over the past year, ACIU annual cash flow from operations has changed by +$9.86 M (+12.79%)
What is AC Immune SA quarterly cash flow from operations?
The current quarterly CFO of ACIU is -$12.60 M
What is the all time high quarterly CFO for AC Immune SA?
AC Immune SA all-time high quarterly cash flow from operations is $80.71 M
What is AC Immune SA quarterly CFO year-on-year change?
Over the past year, ACIU quarterly cash flow from operations has changed by +$3.07 M (+19.58%)
What is AC Immune SA TTM cash flow from operations?
The current TTM CFO of ACIU is $52.07 M
What is the all time high TTM CFO for AC Immune SA?
AC Immune SA all-time high TTM cash flow from operations is $56.77 M
What is AC Immune SA TTM CFO year-on-year change?
Over the past year, ACIU TTM cash flow from operations has changed by +$121.13 M (+175.41%)